Premium
Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non‐invasive or invasive)?
Author(s) -
Avari P.,
Reddy M.,
Oliver N.
Publication year - 2020
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.13942
Subject(s) - medicine , blood sugar , type 1 diabetes , continuous glucose monitoring , continuous monitoring , type 2 diabetes mellitus , diabetes mellitus , intensive care medicine , risk analysis (engineering) , operations management , engineering , endocrinology
Abstract Real‐time continuous glucose monitors using subcutaneous needle‐type sensors continue to develop. The limitations of currently available systems, however, include time lag behind changes in blood glucose, the invasive nature of such systems, and in some cases, their accuracy. Non‐invasive techniques have been developed, but, to date, no commercial device has been successful. A key research priority for people with Type 1 diabetes identified by the James Lind Alliance was to identify ways of monitoring blood glucose constantly and accurately using a discrete device, invasive or non‐invasive. Integration of such a sensor is important in the development of a closed‐loop system and the technology must be rapid, selective and acceptable for continuous use by individuals. The present review provides an update on existing continuous glucose‐sensing technologies, and an overview of emergent techniques, including their accuracy and limitations.